Virtus LifeSci Biotech Products ETF (BBP) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with BBP. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to BBP
BBP charges 0.79% annually. There are 52 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.08%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| State Street Health Care Select Sector SPDR ETF | 0.08% | 41.65B | Dec 1998 | BBP vs XLV | |
| Fidelity MSCI Health Care Index ETF | 0.08% | 3.22B | Oct 2013 | BBP vs FHLC | |
| Vanguard Health Care ETF | 0.09% | 19.00B | Jan 2004 | BBP vs VHT | |
| Portfolio Building Block World Pharma and Biotech ... | 0.13% | 951.16M | Nov 2025 | BBP vs PBPH | |
| Invesco Nasdaq Biotechnology ETF | 0.19% | 74.65M | Jun 2021 | BBP vs IBBQ |
Best Risk-Adjusted Alternatives to BBP
BBP has a PortfoliosLab risk / return rank of 89. There are 9 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 96.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 96 | 57.56M | Dec 2014 | BBP vs BBC | |
| ALPS Medical Breakthroughs ETF | 95 | 213.08M | Dec 2014 | BBP vs SBIO | |
| SPDR S&P Biotech ETF | 94 | 11.10B | Feb 2006 | BBP vs XBI | |
| iShares U.S. Pharmaceuticals ETF | 93 | 1.34B | May 2006 | BBP vs IHE | |
| iShares Neuroscience and Healthcare ETF | 92 | 5.85M | Aug 2022 | BBP vs IBRN |
Top Performing BBP Alternatives (YTD)
BBP is at 22.12% YTD. There are 10 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 41.70%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| ARK Genomic Revolution Multi-Sector ETF | 41.70% | 1.31B | Oct 2014 | BBP vs ARKG | |
| AdvisorShares Psychedelics ETF | 38.20% | 44.37M | Sep 2021 | BBP vs PSIL | |
| Virtus LifeSci Biotech Clinical Trials ETF | 33.75% | 57.56M | Dec 2014 | BBP vs BBC | |
| Roundhill UNH WeeklyPay ETF | 32.80% | 6.01M | Dec 2025 | BBP vs UNHW | |
| SPDR S&P Biotech ETF | 27.62% | 11.10B | Feb 2006 | BBP vs XBI |
Lowest Volatility Alternatives to BBP
BBP has 24.21% 1-year volatility. There are 50 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 0.00%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Loncar Cancer Immunotherapy ETF | 0.00% | 12.73M | Oct 2015 | BBP vs CNCR | |
| Amplify Treatments, Testing and Advancements ETF | 0.00% | 9.68M | Jun 2020 | BBP vs GERM | |
| Horizon Kinetics SPAC Active ETF | 8.63% | 10.11M | Jun 2007 | BBP vs SPAQ | |
| State Street Health Care Select Sector SPDR Premiu... | 10.96% | 16.78M | Jul 2025 | BBP vs XLVI | |
| Milliman Healthcare Inflation Plus ETF | 11.68% | 982.35K | Apr 2026 | BBP vs MHIP |
Lowest Drawdown Alternatives to BBP
BBP has a 1-year max drawdown of -9.28%. There are 6 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as 0.00%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | 9.68M | Jun 2020 | BBP vs GERM | |
| Horizon Kinetics SPAC Active ETF | -4.32% | 10.11M | Jun 2007 | BBP vs SPAQ | |
| First Trust Nasdaq Pharmaceuticals ETF | -7.47% | 36.36M | Sep 2016 | BBP vs FTXH | |
| Invesco Nasdaq Biotechnology ETF | -8.34% | 74.65M | Jun 2021 | BBP vs IBBQ | |
| iShares U.S. Pharmaceuticals ETF | -8.47% | 1.34B | May 2006 | BBP vs IHE |
Other ETFs from Virtus Investment Partners
The 9 most viewed Virtus Investment Partners ETFs shown here include PFFA, UTES, PFFR and span 9 categories. AUM among these funds goes as high as $2B.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| Virtus InfraCap U.S. Preferred Stock ETF | Preferred Stock/Convertible Bonds | 35 | 2.21% | 2.45B | May 2018 | BBP vs PFFA | |
| Virtus Reaves Utilities ETF | Utilities Equities | 18 | 4.53% | 1.39B | Sep 2015 | BBP vs UTES | |
| InfraCap REIT Preferred ETF | Preferred Stock/Convertible Bonds, REIT | 24 | 2.80% | 117.50M | Feb 2017 | BBP vs PFFR | |
| InfraCap MLP ETF | MLPs | 40 | 27.35% | 454.57M | Oct 2014 | BBP vs AMZA | |
| Virtus Terranova U.S. Quality Momentum ETF | Momentum, Large Cap Blend Equities | 30 | 8.81% | 243.22M | Nov 2020 | BBP vs JOET | |
| Virtus Private Credit ETF | Nontraditional Bonds | 2 | -10.02% | 30.38M | Feb 2019 | BBP vs VPC | |
| Virtus Newfleet ABS/MBS ETF | Mortgage Backed Securities | 78 | 1.91% | 112.35M | Feb 2021 | BBP vs VABS | |
| Virtus Duff & Phelps Clean Energy ETF | Sustainable | 62 | 15.10% | 5.97M | Aug 2021 | BBP vs VCLN | |
| Virtus Real Asset Income ETF | REIT | 83 | 22.69% | 18.07M | Feb 2019 | BBP vs VRAI |
Often Compared With BBP
Investors most often compare BBP with FBT, WDNA, TXG. These 20 comparison targets span 7 categories, based on PortfoliosLab usage data.
Compare BBP with Any Fund or Stock
Compare BBP with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair BBP with funds that move differently
Virtus LifeSci Biotech Products ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to BBP.
Explore BBP Diversifiers